4DMedical Limited
FDMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $6 | $3 | $1 | $1 |
| % Growth | 91.9% | 324.4% | -31.8% | – |
| Cost of Goods Sold | $0 | $0 | $25 | $1 |
| Gross Profit | $5 | $3 | -$24 | $0 |
| % Margin | 92.1% | 92.2% | -3,378.6% | 26.6% |
| R&D Expenses | $3 | $1 | $8 | $3 |
| G&A Expenses | $0 | $29 | $23 | $21 |
| SG&A Expenses | $32 | $30 | $25 | $19 |
| Sales & Mktg Exp. | $0 | $1 | $2 | $1 |
| Other Operating Expenses | $0 | $19 | -$12 | $0 |
| Operating Expenses | $35 | $49 | $20 | $22 |
| Operating Income | -$29 | -$47 | -$31 | -$22 |
| % Margin | -499.2% | -1,528.4% | -4,265.8% | -2,105.8% |
| Other Income/Exp. Net | -$1 | $11 | -$0 | -$2 |
| Pre-Tax Income | -$30 | -$36 | -$31 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30 | -$36 | -$31 | -$25 |
| % Margin | -513.7% | -1,179.8% | -4,378% | -2,332.6% |
| EPS | -0.071 | -0.11 | -0.1 | -0.084 |
| % Growth | 35.5% | -10% | -19.8% | – |
| EPS Diluted | -0.14 | -0.097 | -0.1 | -0.084 |
| Weighted Avg Shares Out | 215 | 327 | 300 | 295 |
| Weighted Avg Shares Out Dil | 424 | 370 | 300 | 295 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $4 | $1 | $1 |
| EBITDA | -$46 | -$32 | -$44 | -$35 |
| % Margin | -786.7% | -1,044.6% | -6,099.9% | -3,343.9% |